Cargando…
IFN alfacon-1 may be valuable in the treatment of SARS
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149113/ http://dx.doi.org/10.2165/00128413-200414190-00019 |
_version_ | 1783520740129112064 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7149113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-71491132020-04-13 IFN alfacon-1 may be valuable in the treatment of SARS Inpharma Weekly Clinical Study Springer International Publishing 2013-02-09 2004 /pmc/articles/PMC7149113/ http://dx.doi.org/10.2165/00128413-200414190-00019 Text en © Adis International Ltd 2004 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Clinical Study IFN alfacon-1 may be valuable in the treatment of SARS |
title | IFN alfacon-1 may be valuable in the treatment of SARS |
title_full | IFN alfacon-1 may be valuable in the treatment of SARS |
title_fullStr | IFN alfacon-1 may be valuable in the treatment of SARS |
title_full_unstemmed | IFN alfacon-1 may be valuable in the treatment of SARS |
title_short | IFN alfacon-1 may be valuable in the treatment of SARS |
title_sort | ifn alfacon-1 may be valuable in the treatment of sars |
topic | Clinical Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7149113/ http://dx.doi.org/10.2165/00128413-200414190-00019 |